← FDA Drug Approvals (Drugs@FDA)

PAXLOVID (COPACKAGED)

NDA · New Drug Application · Sponsor: PFIZER · Approved 2023-05-25

Drug application

FDA Application #

NDA217188

Application type

New Drug Application

Brand name

PAXLOVID (COPACKAGED)

Generic name

NIRMATRELVIR AND RITONAVIR

Active ingredients

NIRMATRELVIR; RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2023-05-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown